Pomdoctor Receives Nasdaq Delisting Determination

MT newswire2026/10/09 20:52

04:52 PM EDT, 10/09/2026 (MT Newswires) -- Pomdoctor Limited (POM) said it received a Nasdaq staff determination letter Tuesday stating that its American depositary shares are subject to delisting for failing to meet the minimum bid price requirement. The ADSs closed below $1.00 for 30 consecutive business days, from Aug. 24 through Oct. 5. Pomdoctor is not eligible for a compliance period because it effected a 1-for-18 reverse stock split on June 22, within the prior year. The company intends to request a hearing before a Nasdaq hearings panel by the Oct. 13 deadline. A timely request will stay the trading suspension, which would otherwise take effect Oct. 15, and the filing of a delisting notice pending the panel's decision.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Updated version 1 - According to The Seattle Times, Boeing will lay off 5% of its aircraft manufacturing department employees.

路透社•2026/11/09 18:01

Meta Launches Muse Ember Model to Enhance Complex Reasoning Capabilities

Cointime•2026/11/09 17:51

Meridian weighs $400 million investment decision for Cabaçal mine

Mining.com•2026/11/09 17:18

Charles Schwab Adds Solana, Avalanche and Chainlink to Crypto Trading Platform

Coinedition•2026/11/09 17:15